首页> 美国卫生研究院文献>Molecular Therapy >Cocal-pseudotyped Lentiviral Vectors Resist Inactivation by Human Serum and Efficiently Transduce Primate Hematopoietic Repopulating Cells
【2h】

Cocal-pseudotyped Lentiviral Vectors Resist Inactivation by Human Serum and Efficiently Transduce Primate Hematopoietic Repopulating Cells

机译:Cocal-pseudotyped慢病毒载体抗人血清灭活并有效转导灵长类动物造血繁殖细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lentiviral vectors are established as efficient and convenient vehicles for gene transfer. They are almost always pseudotyped with the envelope glycoprotein of vesicular stomatitis virus (VSV-G) due to the high titers that can be achieved, their stability, and broad tropism. We generated a novel cocal vesiculovirus envelope glycoprotein plasmid and compared the properties of lentiviral vectors pseudotyped with cocal, VSV-G, and a modified feline endogenous retrovirus envelope glycoprotein (RD114/TR). Cocal-pseudotyped lentiviral vectors can be produced at titers as high as with VSV-G, have a broad tropism, and are stable, allowing for efficient concentration by centrifugation. Additionally, cocal vectors are more resistant to inactivation by human serum than VSV-G-pseudotyped vectors, and efficiently transduce human CD34+ nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse–repopulating cells (SRCs), and long-term primate hematopoietic repopulating cells. These studies establish the potential of cocal-pseudotyped lentiviral vectors for a variety of scientific and therapeutic gene transfer applications, including in vivo gene delivery and hematopoietic stem cell (HSC) gene therapy.
机译:慢病毒载体被确立为基因转移的有效且方便的载体。由于可获得的高滴度,稳定性和宽泛性,它们几乎总是被水泡性口炎病毒(VSV-G)的包膜糖蛋白假型化。我们生成了一个新型的结肠水泡膜病毒包膜糖蛋白质粒,并比较了用cocal,VSV-G和修饰的猫内源性逆转录病毒包膜糖蛋白(RD114 / TR)假型化的慢病毒载体的特性。可以以与VSV-G一样高的效价生产Cocal-pseudotyped慢病毒载体,具有广泛的向性,并且稳定,可以通过离心有效浓缩。此外,cocal载体比VSV-G假型载体更能抵抗人类血清的失活,并能有效转导人类CD34 + 非肥胖型糖尿病/重症合并免疫缺陷(NOD / SCID)小鼠再生细胞(SRCs) ),以及长期的灵长类动物造血繁殖细胞。这些研究确立了在任何科学和治疗性基因转移应用中使用cocal-pseudotyped慢病毒载体的潜力,包括体内基因递送和造血干细胞(HSC)基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号